Business Of Biotech Biotech Angel Investing With Yaniv Sneor
15 snips
May 26, 2025 Yaniv Sneor, founder of the Mid Atlantic Bio Angels and CEO at Native State Therapeutics, dives into the world of life science angel investing. He shares how investors evaluate biotech startups and the importance of crafting a compelling pitch. Yaniv discusses red flags for investors, the role of syndicates, and why biotech remains a strong investment sector. He highlights the intricacies of funding timelines and offers valuable insights for emerging drug developers seeking capital in a competitive landscape.
AI Snips
Chapters
Transcript
Episode notes
Specialized Expertise Is Key
- Life science investing requires specific expertise due to its complexity.
- Forming a specialized group brings together industry professionals for thorough diligence.
Rigorous Screening And Diligence
- Screen startups by their fit to your criteria and investment goals first.
- Invite only a few to present and conduct rigorous diligence before investing.
Validate Science And Exit Strategy
- Validate scientific and commercial viability early to avoid wasting resources.
- Focus on teams who understand exit planning and market monetization.